PMID- 25363062 OWN - NLM STAT- MEDLINE DCOM- 20150821 LR - 20221207 IS - 1365-2672 (Electronic) IS - 1364-5072 (Linking) VI - 118 IP - 1 DP - 2015 Jan TI - Probiotic supplementation in systemic nickel allergy syndrome patients: study of its effects on lactic acid bacteria population and on clinical symptoms. PG - 202-11 LID - 10.1111/jam.12685 [doi] AB - AIMS: The study aimed to evaluate the effects of probiotic Lactobacillus reuteri DSM 17938 strain supplementation in patients suffering from systemic nickel allergy syndrome, in terms of modulation of faecal LAB population linked to a reduction of GI and cutaneous symptoms and to an increase of patient's quality of life. METHODS AND RESULTS: A preliminary double-blind randomized placebo-controlled study was planned and a culture-independent method based on denaturing gradient gel electrophoresis (DGGE) analysis coupled to the 16S rRNA gene sequencing was applied to investigate on the dynamics of faecal LAB communities before and during a low-Ni diet, supplemented with the probiotic strain. Moreover, the severity and the frequency of GI and cutaneous reactions as well as patient's clinical condition perception (VAS scores) were estimated by statistical analysis. PCR-DGGE fingerprinting obtained using LAB-specific primers revealed significant shift in faecal community with an increase in biodiversity in patients supplemented with probiotic Lact. reuteri strain. In addition, GI reactions such as symptoms related to meals and type of stools significantly improved only in patients treated with Lact. reuteri, while severity and frequency of cutaneous symptoms (urticaria, itch and eczema) and recurrent abdominal pain (RAP) as well as VAS scores statistically decreased in both groups. CONCLUSIONS: Our preliminary findings suggest that probiotic Lact. reuteri could be a useful supplementation during a low-Ni diet of patients with SNAS, to increase LAB population diversity, which could contribute to restore the intestinal homoeostasis conditions. SIGNIFICANCE AND IMPACT OF THE STUDY: To date, no information is available on probiotics application and on their effects, in terms of intestinal microbiota modulation, on patients suffering from SNAS. Therefore, the identification of dominant LAB community and the study of its shift during the probiotic supplementation could enhance the knowledge of the SNAS syndrome. CI - (c) 2014 The Society for Applied Microbiology. FAU - Randazzo, C L AU - Randazzo CL AD - Department of Agri-food and Environmental Systems Management, University of Catania, Catania, Italy. FAU - Pino, A AU - Pino A FAU - Ricciardi, L AU - Ricciardi L FAU - Romano, C AU - Romano C FAU - Comito, D AU - Comito D FAU - Arena, E AU - Arena E FAU - Saitta, S AU - Saitta S FAU - Caggia, C AU - Caggia C LA - eng PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't DEP - 20141130 PL - England TA - J Appl Microbiol JT - Journal of applied microbiology JID - 9706280 RN - 0 (RNA, Ribosomal, 16S) RN - 7OV03QG267 (Nickel) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Denaturing Gradient Gel Electrophoresis MH - Double-Blind Method MH - Feces/microbiology MH - Female MH - Humans MH - Hypersensitivity/diagnosis/etiology/microbiology/*therapy MH - Lactobacillus/genetics/*isolation & purification MH - *Limosilactobacillus reuteri MH - Middle Aged MH - Nickel/*toxicity MH - Polymerase Chain Reaction MH - Probiotics/*therapeutic use MH - RNA, Ribosomal, 16S MH - Sequence Analysis, DNA MH - Young Adult OTO - NOTNLM OT - Lact. reuteri OT - PCR-DGGE OT - SNAS OT - clinical outcomes OT - faecal samples OT - low-nickel diet EDAT- 2014/11/05 06:00 MHDA- 2015/08/22 06:00 CRDT- 2014/11/04 06:00 PHST- 2014/09/04 00:00 [received] PHST- 2014/10/21 00:00 [revised] PHST- 2014/10/27 00:00 [accepted] PHST- 2014/11/04 06:00 [entrez] PHST- 2014/11/05 06:00 [pubmed] PHST- 2015/08/22 06:00 [medline] AID - 10.1111/jam.12685 [doi] PST - ppublish SO - J Appl Microbiol. 2015 Jan;118(1):202-11. doi: 10.1111/jam.12685. Epub 2014 Nov 30.